References
Lin W, Xin Z, Ning X, Li Y, Ren X, Su Y, Liu M, Guo S, Yang L, Liu Y, Zhang F, Zhang W (2021) ClinRheumatol 40:4081–4087
Herrick A, Muir L (2014) Raynaud’s phenomenon (secondary). BMJ ClinEvid 2014:1125–1132
CutoloM SV, Furst DE, Khanna D, Herrick AL (2017) Points to consider-Raynaud’s phenomenon in systemic sclerosis. Rheumatology (Oxford) 56:v45–v48
Fraenkel L, Zhang Y, Chaisson CE, Evans SR, Wilson PWF, Felson DT (1998) The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women. AnnIntern Med 129:208–211
Wigley FM (2001) Raynaud’s phenomenon is linked to unopposed estrogen replacement therapy in postmenopausal women. ClinExpRheumatol 19:10–11
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, C., Liang, Y. & Yang, Z. Can Raynaud’s phenomenon be defined as a subtype of primary Sjögren’s syndrome? Comments on “Clinical features and risk factors of Raynaud’s phenomenon in primary Sjögren’s syndrome”. Clin Rheumatol 41, 1265–1266 (2022). https://doi.org/10.1007/s10067-021-06023-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-021-06023-9